Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Mochida Pharmaceutical Co., Ltd. ( (JP:4534) ).
Mochida Pharmaceutical Co., Ltd. announced changes in its leadership, with new appointments for representative directors and directors effective June 27, 2025. These changes aim to strengthen the company’s management structure, potentially impacting its operational efficiency and strategic direction.
More about Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on research, pharmaceutical development, business development, and biomaterials. It is known for its pharmaceutical business and healthcare services, with a market presence in the Prime Market.
YTD Price Performance: -11.03%
Average Trading Volume: 26,864
Technical Sentiment Signal: Sell
Current Market Cap: Yen105.3B
Learn more about 4534 stock on TipRanks’ Stock Analysis page.